Diffuse glioma heterogeneity and its therapeutic implications
JG Nicholson, HA Fine - Cancer discovery, 2021 - AACR
Diffuse gliomas represent a heterogeneous group of universally lethal brain tumors
characterized by minimally effective genotype-targeted therapies. Recent advances have …
characterized by minimally effective genotype-targeted therapies. Recent advances have …
[HTML][HTML] Integrin signaling in cancer: mechanotransduction, stemness, epithelial plasticity, and therapeutic resistance
J Cooper, FG Giancotti - Cancer cell, 2019 - cell.com
Integrins mediate cell adhesion and transmit mechanical and chemical signals to the cell
interior. Various mechanisms deregulate integrin signaling in cancer, empowering tumor …
interior. Various mechanisms deregulate integrin signaling in cancer, empowering tumor …
[HTML][HTML] Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment
B Wu, X Shi, M Jiang, H Liu - Molecular Cancer, 2023 - Springer
Ongoing research has revealed that the existence of cancer stem cells (CSCs) is one of the
biggest obstacles in the current cancer therapy. CSCs make an influential function in tumor …
biggest obstacles in the current cancer therapy. CSCs make an influential function in tumor …
[HTML][HTML] Glioblastoma stem cells: driving resilience through chaos
BC Prager, S Bhargava, V Mahadev, CG Hubert… - Trends in cancer, 2020 - cell.com
Glioblastoma is an aggressive and heterogeneous tumor in which glioblastoma stem cells
(GSCs) are at the apex of an entropic hierarchy and impart devastating therapy resistance …
(GSCs) are at the apex of an entropic hierarchy and impart devastating therapy resistance …
[HTML][HTML] The microenvironmental landscape of brain tumors
DF Quail, JA Joyce - Cancer cell, 2017 - cell.com
The brain tumor microenvironment (TME) is emerging as a critical regulator of cancer
progression in primary and metastatic brain malignancies. The unique properties of this …
progression in primary and metastatic brain malignancies. The unique properties of this …
[HTML][HTML] Macrophages and microglia: the cerberus of glioblastoma
A Buonfiglioli, D Hambardzumyan - Acta neuropathologica …, 2021 - Springer
Glioblastoma (GBM) is the most aggressive and deadliest of the primary brain tumors,
characterized by malignant growth, invasion into the brain parenchyma, and resistance to …
characterized by malignant growth, invasion into the brain parenchyma, and resistance to …
Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance.
Temozolomide (TMZ) is a first-choice alkylating agent inducted as a gold standard therapy
for glioblastoma multiforme (GBM) and astrocytoma. A majority of patients do not respond to …
for glioblastoma multiforme (GBM) and astrocytoma. A majority of patients do not respond to …
[HTML][HTML] Outer radial glia-like cancer stem cells contribute to heterogeneity of glioblastoma
Glioblastoma is a devastating form of brain cancer. To identify aspects of tumor
heterogeneity that may illuminate drivers of tumor invasion, we created a glioblastoma tumor …
heterogeneity that may illuminate drivers of tumor invasion, we created a glioblastoma tumor …
[HTML][HTML] The glioma stem cell model in the era of single-cell genomics
Glioma stem cells (GSCs) are thought to underlie glioma initiation, evolution, and resistance
to existing therapies. Although functional evidence for GSCs is abundant, tumor …
to existing therapies. Although functional evidence for GSCs is abundant, tumor …
Cancer stem cells: A review from origin to therapeutic implications
Cancer stem cells (CSCs), also known as tumor‐initiating cells (TICs), are elucidated as
cells that can perpetuate themselves via autorestoration. These cells are highly resistant to …
cells that can perpetuate themselves via autorestoration. These cells are highly resistant to …